Hoth Therapeutics (HOTH) Institutional Ownership $1.28 -0.01 (-0.78%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.32 +0.04 (+3.13%) As of 08/15/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Hoth Therapeutics (NASDAQ:HOTH)CurrentInstitutional OwnershipPercentage7.08%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$49.09KNumber ofInstitutional Sellers(last 12 months)0 Get HOTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Hoth Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HOTH Institutional Buying and Selling by Quarter Hoth Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025 Geode Capital Management LLC122,575$143K0.0%+8.0%0.928% 2/12/2025 Geode Capital Management LLC95,946$72K0.0%+15.7%1.391% 11/20/2024 Virtu Financial LLC32,636$29K0.0%N/A0.473% 8/15/2024 Armistice Capital LLC213,000$194K0.0%-48.0%3.975% 8/16/2021 State Street Corp27,100$43K0.0%N/A0.114% 8/13/2021 Geode Capital Management LLC79,571$127K0.0%+323.4%0.333% 8/13/2021 Vanguard Group Inc.706,195$1.13M0.0%+650.7%2.958% 5/21/2021 Citadel Advisors LLC79,758$157K0.0%+137.4%0.334% (Data available from 1/1/2016 forward) HOTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HOTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Hoth Therapeutics shares: Armistice Capital LLC ($194K), and Geode Capital Management LLC ($143K), Virtu Financial LLC ($29K).Learn more on Hoth Therapeutics' institutional investors. What percentage of Hoth Therapeutics' stock is owned by institutional investors? 7.08% of Hoth Therapeutics' stock is owned by institutional investors. Learn more on HOTH's institutional investor holdings. Which institutional investors have been buying Hoth Therapeutics' stock? The following institutional investors have purchased Hoth Therapeutics' stock in the last 24 months: Virtu Financial LLC ($32.64K), and Geode Capital Management LLC ($22.11K). How much institutional buying is happening at Hoth Therapeutics? Institutional investors have bought a total of 54,745 shares in the last 24 months. This purchase volume represents approximately $49.09K in transactions. Related Companies Cue Biopharma Major Shareholders Invizyne Technologies Major Shareholders Applied Therapeutics Major Shareholders ImmuCell Major Shareholders ImageneBio Major Shareholders Verrica Pharmaceuticals Major Shareholders DURECT Major Shareholders Biomea Fusion Major Shareholders Cognition Therapeutics Major Shareholders Barinthus Biotherapeutics Major Shareholders This page (NASDAQ:HOTH) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access